Entresto 24 MG-26 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FVKK2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,894
Award facts
- Contract value 100% obligated
- $50,894.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $50,894.44 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 5, 2025. The order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a child delivery order, this award is issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Entresto, a combination medication for heart failure treatment, represents one of many specialty pharmaceutical products the contractor supplies through its extensive DLA portfolio. The company's demonstrated capability to fulfill federal medical supply requirements through competitive procurement has established it as a key participant in the Defense Logistics Agency's pharmaceutical supply chain, with contract awards spanning a broad therapeutic spectrum including specialty medications, vaccines, and medical devices.
Quick answers
Who was awarded contract SPE2DB25FVKK2?
SPE2DB25FVKK2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FVKK2 worth?
The government has obligated $50,894 on SPE2DB25FVKK2.
Is contract SPE2DB25FVKK2 an order under another contract?
Yes. SPE2DB25FVKK2 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVKK2 competed?
The extent of competition for SPE2DB25FVKK2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award